logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-33. Mean age at first use and mean age at entering treatment by gender and primary drug among new clients entering treatment, 2011 or most recent year available

Part (i) Outpatient units

Primary drugMalesFemalesTotal
Mean age at first useMean age at entering treatmentTime lag between first use and first treatment demandMean age at first useMean age at entering treatmentTime lag between first use and first treatment demandMean age at first useMean age at entering treatmentTime lag between first use and first treatment demand
Opiods23341123329233411
Cocaine22331123329223311
Stimulants202882026620288
Cannabis172471624817247
 

Notes:

For information relative to the countries included, please see Table TDI-7

See also ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012 — Outpatient treatment centres.

Page last updated: Friday, 26 April 2013